Back to results

CompletedN/A

ExAblate (MRgFUS) Treatment of Metastatic Bone Tumors for the Palliation of Pain

NCT00656305

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

University of California San Diego

La Jolla, California, United States

+13 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2008-03
Enrollment: 147 participants
Sponsor: InSightec
Purpose: treatment

Locations (14)

University of California San DiegoLa Jolla, California, United States
Stanford University Medical CenterStanford, California, United States
University MRI & Diagnostic Imaging CentersBoca Raton, Florida, United States
Moffitt Cancer CenterTampa, Florida, United States
Brigham and Women's HospitalBoston, Massachusetts, United States
Weill Cornell Medical CollegeNew York, New York, United States
Fox Chase Cancer CenterPhiladelphia, Pennsylvania, United States
University of Virginia Health SystemCharlottesville, Virginia, United States
Toronto General HospitalToronto, Ontario, Canada
Rambam medical Center -The Pain palliation unitHaifa, Israel
Sheba Medical CenterTel Litwinsky, Israel
University of Rome "La Sapienza"Rome, Italy
Rostov State Research Institute of OncologyRostov-on-Don, Russia
N. N. Petrov Institute of OncologySaint Petersburg, Russia

ExAblate (MRgFUS) Treatment of Metastatic Bone Tumors for the Palliation of Pain — TrialFind